1H-NMR and 13C-NMR dataset for some oxidative metabolites of CRA13 and their analogs

1H-NMR and 13C-NMR dataset for some oxidative metabolites of CRA13 and their analogs

CRA13 (CB-13; SAB-378) is a dual CB1R/CB2R agonist cannabinoid agent developed by Novartis Pharma. Upon administration, it undergoes metabolism to oxidative metabolites. Herein, the 1H-NMR and 13C-NMR dataset of some oxidative metabolites and analogs thereof are presented for further analysis and co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Data in brief 2018-12, Vol.21, p.485-500
Hauptverfasser: Hassan, Ahmed H.E., Cho, Min Chang, Kim, Hye In, Yang, Ji Seul, Park, Kyung Tae, Lee, Yong Sup
Format: Artikel
Sprache:eng
Schlagworte:
Chemistry
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:CRA13 (CB-13; SAB-378) is a dual CB1R/CB2R agonist cannabinoid agent developed by Novartis Pharma. Upon administration, it undergoes metabolism to oxidative metabolites. Herein, the 1H-NMR and 13C-NMR dataset of some oxidative metabolites and analogs thereof are presented for further analysis and comparison purposes, for whom may be interested.
ISSN:2352-3409
2352-3409
DOI:10.1016/j.dib.2018.09.069